On March 1, 2024, the U.S. FDA approved RYBREVANT in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients with locally advanced or metastatic NSCLC with EGFR ...
(RTTNews) - The China stock market has tracked higher in back-to-back sessions, advancing more than 30 points or 1.1 percent along the way. The Shanghai Composite now sits just above the 2,735-point ...
(RTTNews) - The Taiwan stock market moved back to the upside on Thursday, one session after ending the three-day winning streak in which it had rallied more than 810 points or 3.9 percent. The Taiwan ...
Coffee prices retreated Thursday as forecasts for rain in Brazil sparked long liquidation coffee futures. Thursday's two-week Global Forecast System model showed rain is expected for Brazil's ...
(RTTNews) - The Singapore stock market bounced higher again on Thursday, one day after halting the seven-day winning streak in which it had surged more than 140 points or 3.9 percent. The Straits ...